KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma.
Sinn BV, Striefler JK, Rudl MA, Lehmann A, Bahra M, Denkert C, Sinn M, Stieler J, Klauschen F, Budczies J, Weichert W, Stenzinger A, Kamphues C, Dietel M, Riess H.
Sinn BV, et al. Among authors: bahra m.
Pancreas. 2014 May;43(4):578-83. doi: 10.1097/MPA.0000000000000077.
Pancreas. 2014.
PMID: 24681874